Representative Pete Sessions (R-TX) is urging fellow members of Congress in Washington, D.C., to support a bill that would provide an alternative healthcare option for Americans via an insurance tax credit, reducing accessibility and cost barriers.
The Health Care Fairness for All (Fair) Act restructures key parts of the Affordable Care Act by replacing certain subsidies and mandates with universal tax credits. These credits can be used to purchase private insurance, pay qualified medical expenses and contribute to expanded Health Savings Accounts with Roth-like tax advantages.
Although the Fair Act has been reintroduced multiple times since its first appearance in 2023, Rep. Sessions continues to stress the importance of the legislation today.
“Our current healthcare system puts countless American families and individuals in no-win circumstances, forcing high costs and little choice,” Rep. Sessions said.
Dean Clancy, senior health policy fellow at Americans for Prosperity, explained that the bill makes healthcare more affordable in three key ways: it funds patients rather than insurance companies, expands tax-advantaged health savings accounts and reduces barriers to care while preserving protections for people with pre-existing conditions.
“Under this bill, if you like your current health coverage, you can keep it,” Clancy said. “But if you want lower prices, more freedom, and fairness for all — this bill's for you.”
By allowing Americans to gain autonomy over healthcare decisions, Rep. Sessions said the bill would incentivize private markets to be more “innovative” and “competitive,” resulting in lower costs and a more accessible healthcare marketplace.
“Our country should have a healthcare system that reflects its founding principles of freedom and opportunity,” he said.
Rep. Sessions also stressed the importance of assisting those with pre-existing conditions. He said the bill builds on earlier “Right to Try” policies that allow patients with severe illness access to promising medical treatments and clinical trials not yet approved by the Federal Drug Administration.
“We're trying to bring drugs quicker, results quicker and give it to people to save lives,” Rep. Sessions said.
